DSwiss, Inc.

DSwiss, Inc., a biotech-nutraceutical company, supplies health and beauty products in Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. Its products include DSwiss coffee for digestive health; DSwiss kiwi, which helps the body's immune system, as well as enhances skin complexion, reduces blood pressure, and prevents heart disease and stroke; DSwiss Triple SC that focuses on stem cells; DSwiss silk mask, a mask for dry, damaged, and sensitive skin; DSwiss coffee slimming scrub, a natural body scrub for removing dirt on the skin layers; DSwiss peppermint slimming gel, a cooling agent; DSwiss new age essence delivers nutrients to moisten, brighten, and revive tired looking skin; and DSwiss enlighten essence cream, a light and nourishing cream. The company also provides DSwiss BioSpec, a medical eye-wear; Genmune-Pro, a product that helps the human's immunity system through enhancing the digestive health; SkinEra, a skin solution for acne, pimples, atopic dermatitis, dry skin, and allergy rashes; SensiBath gel; SuiSu hand purifiers and sanitizers, and air sanitizers; and MasterLiv to help support liver health, MasterHeart to help maintain optimum heart health and smooth blood circulation, and WellG, which offers nutrients needed for the metabolism of sugar and energy production. In addition, it provides DSwiss quantum magnetic analyzer, an equipment that reads and analyzes body energy field to test the health status and suggest recommendations; and AI skin analyzer machine, a facial camera for facial skin image data, as well as turnkey private label manufacturing services. Further, the company offers medical consumables, including surgical gowns and gloves, 3-ply face masks, N95 masks, protective goggles, body infrared thermometers, disposable bedsheets, and stretcher covers; and DNA microarray genotyping services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.

DSwiss, Inc. trades as DQWS on OTC. The company is classified in Consumer Defensive / Household & Personal Products and reports in USD.

The current profile places the business in Household & Personal Products. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $2.92M of revenue and -$76,860 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

DSwiss, Inc. can be compared against peers such as BAB, Inc., CCA Industries, Inc., CleanGo Innovations Inc., Merion, Inc., Green Globe International, Inc., YaSheng Group.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $8.69M, beta of -1.73, and return on equity of +822.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

DQWS currently shows total debt of $282,274 and beta of -1.73. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 10-Q (2026-05-15 00:00:00), 10-K (2026-03-31 00:00:00), 10-Q (2025-11-14 00:00:00), 8-K (2025-10-06 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.dswissbeauty.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.